Your browser doesn't support javascript.
loading
Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up.
van Mierlo, Tom J M; Foncke, Elisabeth M J; Post, Bart; Schmand, Ben A; Bloem, Bastiaan R; van Harten, Barbera; Tissingh, Gerrit; Munts, Alexander G; de Haan, Rob J; de Bie, Rob M A.
  • van Mierlo TJM; Department of Neurology, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam University, Medical Centers, Amsterdam, The Netherlands.
  • Foncke EMJ; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • Post B; Department of Neurology, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam University, Medical Centers, Amsterdam, The Netherlands.
  • Schmand BA; Department of Neurology and Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Bloem BR; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
  • van Harten B; Department of Neurology and Centre of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Tissingh G; Department of Neurology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Munts AG; Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • de Haan RJ; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • de Bie RMA; Clinical Research Unit, Amsterdam Neuroscience, University of Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Brain Behav ; 11(8): e2257, 2021 08.
Article en En | MEDLINE | ID: mdl-34291590

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article